The association of spirometric small airways obstruction with respiratory symptoms, cardiometabolic diseases, and quality of life: results from the Burden of Obstructive Lung Disease (BOLD) study
Authors:
- Ben Knox-BrownBKBen Knox-Brown
- Jaymini PatelJPJaymini Patel
- James PottsJPJames Potts
- Rana AhmedRARana Ahmed
- Althea Aquart-StewartAAAlthea Aquart-Stewart
- Cristina BarbaraCBCristina Barbara
- A. Sonia BuistABA. Sonia Buist
- Hamid Hacene CherkaskiHCHamid Hacene Cherkaski
- Meriam DenguezliMDMeriam Denguezli
- Mohammed ElbiazeMEMohammed Elbiaze
- Gregory E. ErhaborGEGregory E. Erhabor
- Frits M. E. FranssenFFFrits M. E. Franssen
Open Access
- 23 May 2023
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 24 (1) , 1-15
Abstract
Background: Spirometric small airways obstruction (SAO) is common in the general population. Whether spirometric SAO is associated with respiratory symptoms, cardiometabolic diseases, and quality of life (QoL) is unknown. Methods: Using data from the Burden of Obstructive Lung Disease study (N = 21,594), we defined spirometric SAO as the mean forced expiratory flow rate between 25 and 75% of the FVC (FEF25-75) less than the lower limit of normal (LLN) or the forced expiratory volume in 3 s to FVC ratio (FEV3/FVC) less than the LLN. We analysed data on respiratory symptoms, cardiometabolic diseases, and QoL collected using standardised questionnaires. We assessed the associations with spirometric SAO using multivariable regression models, and pooled site estimates using random effects meta-analysis. We conducted identical analyses for isolated spirometric SAO (i.e. with FEV1/FVC ≥ LLN). Results: Almost a fifth of the participants had spirometric SAO (19% for FEF25-75; 17% for FEV3/FVC). Using FEF25-75, spirometric SAO was associated with dyspnoea (OR = 2.16, 95% CI 1.77–2.70), chronic cough (OR = 2.56, 95% CI 2.08–3.15), chronic phlegm (OR = 2.29, 95% CI 1.77–4.05), wheeze (OR = 2.87, 95% CI 2.50–3.40) and cardiovascular disease (OR = 1.30, 95% CI 1.11–1.52), but not hypertension or diabetes. Spirometric SAO was associated with worse physical and mental QoL. These associations were similar for FEV3/FVC. Isolated spirometric SAO (10% for FEF25-75; 6% for FEV3/FVC), was also associated with respiratory symptoms and cardiovascular disease. Conclusion: Spirometric SAO is associated with respiratory symptoms, cardiovascular disease, and QoL. Consideration should be given to the measurement of FEF25-75 and FEV3/FVC, in addition to traditional spirometry parameters.Keywords
Funding Information
- Wellcome Trust (085790/Z/08/Z)
This publication has 40 references indexed in Scilit:
- Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007–2010Respiratory Research, 2013
- Left Ventricular Failure Produces Profound Lung Remodeling and Pulmonary Hypertension in MiceHypertension, 2012
- Early Community Contexts, Race/Ethnicity and Young Adult CVD Risk Factors: The Protective Role of EducationJournal of Community Health, 2011
- Chronic obstructive pulmonary disease and the risk of cardiovascular diseasesEuropean Journal of Epidemiology, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- Discriminating Measures and Normal Values for Expiratory ObstructionChest, 2006
- Fixed Effects vs. Random Effects Meta‐Analysis Models: Implications for Cumulative Research KnowledgeInternational Journal of Selection and Assessment, 2000
- Sex, Age, Cardiovascular Risk Factors, and Coronary Heart DiseaseCirculation, 1999
- Spirometric Reference Values from a Sample of the General U.S. PopulationAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine CountriesJournal of Clinical Epidemiology, 1998